Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression

CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer

(2010) J.L. Hao et al.   CURRENT CANCER DRUG TARGETS

CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts

(2009) E Marangoni et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells

(2009) Mark G. Slomiany et al.   CANCER RESEARCH

Anti-EMMPRIN Monoclonal Antibody as a Novel Agent for Therapy of Head and Neck Cancer

(2009) N. R. Dean et al.   CLINICAL CANCER RESEARCH

The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer

(2009) Céline Pinheiro et al.   EUROPEAN JOURNAL OF CANCER

CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models

(2009) W Schneiderhan et al.   GUT

Lipoplexes Targeting the CD44 Hyaluronic Acid Receptor for Efficient Transfection of Breast Cancer Cells

(2009) Claudio Surace et al.   MOLECULAR PHARMACEUTICS

Hyaluronic Acid-Modified DOTAP/DOPE Liposomes for the Targeted Delivery of Anti-Telomerase siRNA to CD44-Expressing Lung Cancer Cells

(2009) Sebastian Taetz et al.   OLIGONUCLEOTIDES

The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression

(2008) Michele C. Madigan et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis

(2008) Juan Su et al.   CANCER LETTERS

Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading

(2008) M. J. Albers et al.   CANCER RESEARCH

Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance

(2008) Bryan P. Toole et al.   DRUG RESISTANCE UPDATES

Increasing Expression of Monocarboxylate Transporters 1 and 4 Along Progression to Invasive Cervical Carcinoma

(2008) Céline Pinheiro et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

An insight on hyaluronic acid in drug targeting and drug delivery

(2008) Awesh K. Yadav et al.   JOURNAL OF DRUG TARGETING

Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan Receptor

(2008) Virginia M. Platt et al.   MOLECULAR PHARMACEUTICS

CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer

(2008) Wei-de Zhong et al.   ONCOLOGY

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas

(2008) Céline Pinheiro et al.   VIRCHOWS ARCHIV

The Multidrug Transporter P-Glycoprotein: A Mediator of Melanoma Invasion?

(2007) Marisa Colone et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY